Wbi Investments, Inc. Eli Lilly & CO Transaction History

Wbi Investments, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$221.6 - $272.71 $740,587 - $911,396	-3,342 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $573,607 - $741,956	3,177 Added 1925.45%	3,342 $767,000
Q2 2021 Aug 09, 2021	BUY	$180.55 - $233.54 $29,790 - $38,534	165 New	165 $767,000
Q1 2018 May 10, 2018	SELL	$74.21 - $87.6 $17.3 Million - $20.4 Million	-233,094 Closed	0 $0
Q4 2017 Feb 08, 2018	BUY	$81.94 - $87.89 $19.1 Million - $20.5 Million	233,094 New	233,094 $19.7 Million
Q3 2017 Nov 13, 2017	SELL	$77.07 - $85.54 $16.7 Million - $18.6 Million	-216,915 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	216,915	216,915 $17.9 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Wbi Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Wbi Investments, Inc. with notifications on news.